nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—CHRM2—Dimenhydrinate—atopic dermatitis	0.108	0.247	CbGbCtD
Methotrimeprazine—HRH1—Dimenhydrinate—atopic dermatitis	0.0987	0.225	CbGbCtD
Methotrimeprazine—Trimipramine—Diphenhydramine—atopic dermatitis	0.0791	0.19	CrCrCtD
Methotrimeprazine—Dimetacrine—Diphenhydramine—atopic dermatitis	0.0757	0.181	CrCrCtD
Methotrimeprazine—Imipramine—Diphenhydramine—atopic dermatitis	0.0726	0.174	CrCrCtD
Methotrimeprazine—Promethazine—Diphenhydramine—atopic dermatitis	0.0671	0.161	CrCrCtD
Methotrimeprazine—Alimemazine—Diphenhydramine—atopic dermatitis	0.0659	0.158	CrCrCtD
Methotrimeprazine—Promazine—Diphenhydramine—atopic dermatitis	0.0568	0.136	CrCrCtD
Methotrimeprazine—CHRM2—Diphenhydramine—atopic dermatitis	0.0528	0.12	CbGbCtD
Methotrimeprazine—HRH1—Loratadine—atopic dermatitis	0.0482	0.11	CbGbCtD
Methotrimeprazine—HRH1—Diphenhydramine—atopic dermatitis	0.0482	0.11	CbGbCtD
Methotrimeprazine—CYP1A2—Diphenhydramine—atopic dermatitis	0.0234	0.0533	CbGbCtD
Methotrimeprazine—CYP2D6—Loratadine—atopic dermatitis	0.0192	0.0439	CbGbCtD
Methotrimeprazine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0192	0.0439	CbGbCtD
Methotrimeprazine—DRD5—eyelid—atopic dermatitis	0.0145	0.464	CbGeAlD
Methotrimeprazine—CYP2E1—Dexamethasone—atopic dermatitis	0.014	0.0319	CbGbCtD
Methotrimeprazine—CYP2D6—Dexamethasone—atopic dermatitis	0.00666	0.0152	CbGbCtD
Methotrimeprazine—CHRM5—skin epidermis—atopic dermatitis	0.00407	0.13	CbGeAlD
Methotrimeprazine—Drug interaction—Loratadine—atopic dermatitis	0.00142	0.0452	CcSEcCtD
Methotrimeprazine—Photosensitivity—Dimenhydrinate—atopic dermatitis	0.00141	0.045	CcSEcCtD
Methotrimeprazine—Photosensitivity—Diphenhydramine—atopic dermatitis	0.00141	0.045	CcSEcCtD
Methotrimeprazine—CHRM5—skin of body—atopic dermatitis	0.00126	0.0403	CbGeAlD
Methotrimeprazine—Urinary retention—Dimenhydrinate—atopic dermatitis	0.00118	0.0376	CcSEcCtD
Methotrimeprazine—Urinary retention—Diphenhydramine—atopic dermatitis	0.00118	0.0376	CcSEcCtD
Methotrimeprazine—Liver injury—Tacrolimus—atopic dermatitis	0.00107	0.034	CcSEcCtD
Methotrimeprazine—CHRM4—head—atopic dermatitis	0.00105	0.0337	CbGeAlD
Methotrimeprazine—DRD3—head—atopic dermatitis	0.000979	0.0313	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Dimenhydrinate—atopic dermatitis	0.000978	0.0312	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Diphenhydramine—atopic dermatitis	0.000978	0.0312	CcSEcCtD
Methotrimeprazine—Drowsiness—Diphenhydramine—atopic dermatitis	0.000955	0.0304	CcSEcCtD
Methotrimeprazine—Drowsiness—Dimenhydrinate—atopic dermatitis	0.000955	0.0304	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Pimecrolimus—atopic dermatitis	0.000945	0.0301	CcSEcCtD
Methotrimeprazine—DRD5—head—atopic dermatitis	0.000918	0.0293	CbGeAlD
Methotrimeprazine—Hepatocellular injury—Tacrolimus—atopic dermatitis	0.000898	0.0286	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Dimenhydrinate—atopic dermatitis	0.000891	0.0284	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Diphenhydramine—atopic dermatitis	0.000891	0.0284	CcSEcCtD
Methotrimeprazine—CHRM5—head—atopic dermatitis	0.000823	0.0263	CbGeAlD
Methotrimeprazine—ADRA1B—head—atopic dermatitis	0.000752	0.0241	CbGeAlD
Methotrimeprazine—Photosensitivity—Tacrolimus—atopic dermatitis	0.000742	0.0237	CcSEcCtD
Methotrimeprazine—ADRA1D—head—atopic dermatitis	0.000736	0.0235	CbGeAlD
Methotrimeprazine—Drowsiness—Loratadine—atopic dermatitis	0.000735	0.0234	CcSEcCtD
Methotrimeprazine—DRD1—head—atopic dermatitis	0.000701	0.0224	CbGeAlD
Methotrimeprazine—HTR2A—neck—atopic dermatitis	0.000647	0.0207	CbGeAlD
Methotrimeprazine—Urinary retention—Tacrolimus—atopic dermatitis	0.00062	0.0198	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Tacrolimus—atopic dermatitis	0.000595	0.019	CcSEcCtD
Methotrimeprazine—Tachycardia—Diphenhydramine—atopic dermatitis	0.000594	0.019	CcSEcCtD
Methotrimeprazine—Tachycardia—Dimenhydrinate—atopic dermatitis	0.000594	0.019	CcSEcCtD
Methotrimeprazine—CHRM2—head—atopic dermatitis	0.000565	0.0181	CbGeAlD
Methotrimeprazine—HTR2C—head—atopic dermatitis	0.000545	0.0174	CbGeAlD
Methotrimeprazine—Somnolence—Diphenhydramine—atopic dermatitis	0.000541	0.0173	CcSEcCtD
Methotrimeprazine—Somnolence—Dimenhydrinate—atopic dermatitis	0.000541	0.0173	CcSEcCtD
Methotrimeprazine—Constipation—Diphenhydramine—atopic dermatitis	0.000521	0.0166	CcSEcCtD
Methotrimeprazine—Constipation—Dimenhydrinate—atopic dermatitis	0.000521	0.0166	CcSEcCtD
Methotrimeprazine—CHRM1—head—atopic dermatitis	0.000514	0.0164	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Tacrolimus—atopic dermatitis	0.000514	0.0164	CcSEcCtD
Methotrimeprazine—Weight increased—Tacrolimus—atopic dermatitis	0.000513	0.0163	CcSEcCtD
Methotrimeprazine—Constipation—Pimecrolimus—atopic dermatitis	0.000504	0.0161	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Fluocinonide—atopic dermatitis	0.000498	0.0159	CcSEcCtD
Methotrimeprazine—Jaundice—Tacrolimus—atopic dermatitis	0.00049	0.0156	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Tacrolimus—atopic dermatitis	0.000469	0.0149	CcSEcCtD
Methotrimeprazine—CHRM3—head—atopic dermatitis	0.00046	0.0147	CbGeAlD
Methotrimeprazine—Tachycardia—Loratadine—atopic dermatitis	0.000458	0.0146	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000434	0.0138	CcSEcCtD
Methotrimeprazine—ADRA1A—head—atopic dermatitis	0.000423	0.0135	CbGeAlD
Methotrimeprazine—Somnolence—Loratadine—atopic dermatitis	0.000417	0.0133	CcSEcCtD
Methotrimeprazine—DRD2—head—atopic dermatitis	0.000414	0.0132	CbGeAlD
Methotrimeprazine—ADRA2C—head—atopic dermatitis	0.000403	0.0129	CbGeAlD
Methotrimeprazine—Constipation—Loratadine—atopic dermatitis	0.000401	0.0128	CcSEcCtD
Methotrimeprazine—Weight increased—Prednisolone—atopic dermatitis	0.000328	0.0104	CcSEcCtD
Methotrimeprazine—HRH1—head—atopic dermatitis	0.000327	0.0105	CbGeAlD
Methotrimeprazine—ADRA2A—head—atopic dermatitis	0.000321	0.0103	CbGeAlD
Methotrimeprazine—Weight increased—Hydrocortisone—atopic dermatitis	0.00032	0.0102	CcSEcCtD
Methotrimeprazine—CYP2E1—head—atopic dermatitis	0.000314	0.0101	CbGeAlD
Methotrimeprazine—Tachycardia—Tacrolimus—atopic dermatitis	0.000313	0.00997	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000311	0.0099	CcSEcCtD
Methotrimeprazine—Weight increased—Triamcinolone—atopic dermatitis	0.000301	0.0096	CcSEcCtD
Methotrimeprazine—Weight increased—Methylprednisolone—atopic dermatitis	0.000301	0.00958	CcSEcCtD
Methotrimeprazine—Somnolence—Tacrolimus—atopic dermatitis	0.000285	0.00908	CcSEcCtD
Methotrimeprazine—Constipation—Tacrolimus—atopic dermatitis	0.000274	0.00874	CcSEcCtD
Methotrimeprazine—HTR2A—head—atopic dermatitis	0.000273	0.00874	CbGeAlD
Methotrimeprazine—Weight increased—Dexamethasone—atopic dermatitis	0.000273	0.00871	CcSEcCtD
Methotrimeprazine—Weight increased—Betamethasone—atopic dermatitis	0.000273	0.00871	CcSEcCtD
Methotrimeprazine—CYP2D6—head—atopic dermatitis	0.000249	0.00796	CbGeAlD
Methotrimeprazine—Weight increased—Prednisone—atopic dermatitis	0.000238	0.00759	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000236	0.00753	CcSEcCtD
Methotrimeprazine—Tachycardia—Prednisolone—atopic dermatitis	0.0002	0.00637	CcSEcCtD
Methotrimeprazine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000195	0.00622	CcSEcCtD
Methotrimeprazine—Tachycardia—Triamcinolone—atopic dermatitis	0.000184	0.00586	CcSEcCtD
Methotrimeprazine—Tachycardia—Methylprednisolone—atopic dermatitis	0.000183	0.00584	CcSEcCtD
Methotrimeprazine—Tachycardia—Dexamethasone—atopic dermatitis	0.000167	0.00531	CcSEcCtD
Methotrimeprazine—Tachycardia—Betamethasone—atopic dermatitis	0.000167	0.00531	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Prednisolone—atopic dermatitis	0.000151	0.00481	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000147	0.00469	CcSEcCtD
Methotrimeprazine—Tachycardia—Prednisone—atopic dermatitis	0.000145	0.00463	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000139	0.00442	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000138	0.00441	CcSEcCtD
Methotrimeprazine—Constipation—Prednisone—atopic dermatitis	0.000127	0.00405	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Prednisone—atopic dermatitis	0.00011	0.00349	CcSEcCtD
Methotrimeprazine—CHRM3—Signaling Pathways—IL5—atopic dermatitis	1.38e-05	0.000169	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—CXCL8—atopic dermatitis	1.37e-05	0.000169	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.37e-05	0.000169	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CCR5—atopic dermatitis	1.37e-05	0.000168	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CCL5—atopic dermatitis	1.37e-05	0.000168	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	1.36e-05	0.000167	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL5—atopic dermatitis	1.36e-05	0.000167	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL5—atopic dermatitis	1.36e-05	0.000167	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	1.36e-05	0.000167	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	1.36e-05	0.000167	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	1.35e-05	0.000166	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CCL5—atopic dermatitis	1.35e-05	0.000166	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CCL5—atopic dermatitis	1.35e-05	0.000166	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—IL2—atopic dermatitis	1.34e-05	0.000165	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—NGF—atopic dermatitis	1.33e-05	0.000163	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	1.33e-05	0.000163	CbGpPWpGaD
Methotrimeprazine—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	1.33e-05	0.000163	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	1.33e-05	0.000163	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	1.33e-05	0.000163	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	1.32e-05	0.000162	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—IL2—atopic dermatitis	1.31e-05	0.000161	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	1.31e-05	0.000161	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	1.3e-05	0.00016	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	1.3e-05	0.000159	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—NGF—atopic dermatitis	1.27e-05	0.000156	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	1.27e-05	0.000156	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	1.26e-05	0.000155	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	1.26e-05	0.000155	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—NGF—atopic dermatitis	1.25e-05	0.000154	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—NGF—atopic dermatitis	1.25e-05	0.000154	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—CXCL8—atopic dermatitis	1.25e-05	0.000153	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	1.25e-05	0.000153	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.24e-05	0.000152	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CCR5—atopic dermatitis	1.24e-05	0.000152	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	1.22e-05	0.00015	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CCR5—atopic dermatitis	1.22e-05	0.00015	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CCR5—atopic dermatitis	1.22e-05	0.00015	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—IL2—atopic dermatitis	1.21e-05	0.000148	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	1.2e-05	0.000148	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	1.19e-05	0.000146	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—IL2—atopic dermatitis	1.19e-05	0.000146	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	1.19e-05	0.000146	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.19e-05	0.000146	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	1.19e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	1.18e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	1.18e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PPARA—atopic dermatitis	1.18e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	1.18e-05	0.000144	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	1.17e-05	0.000144	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	1.17e-05	0.000144	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	1.16e-05	0.000143	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	1.16e-05	0.000143	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CXCL10—atopic dermatitis	1.16e-05	0.000142	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	1.16e-05	0.000142	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	1.15e-05	0.000141	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	1.14e-05	0.00014	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.14e-05	0.00014	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	1.14e-05	0.00014	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	1.13e-05	0.000139	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	1.13e-05	0.000138	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—CXCL8—atopic dermatitis	1.12e-05	0.000138	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	1.12e-05	0.000138	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	1.11e-05	0.000136	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	1.1e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	1.1e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	1.09e-05	0.000134	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NGF—atopic dermatitis	1.09e-05	0.000133	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	1.08e-05	0.000133	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	1.08e-05	0.000132	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	1.08e-05	0.000132	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—IL2—atopic dermatitis	1.07e-05	0.000132	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling by GPCR—IL6—atopic dermatitis	1.07e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	1.06e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	1.06e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	1.05e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.05e-05	0.000129	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	1.05e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PPARA—atopic dermatitis	1.04e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	1.04e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	1.04e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CCL5—atopic dermatitis	1.04e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.03e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	1.03e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	1.03e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	1.03e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.03e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.03e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	1.03e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.03e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	1.02e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CCL5—atopic dermatitis	1.02e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.02e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	1.01e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—CXCL8—atopic dermatitis	1.01e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	1.01e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	1.01e-05	0.000124	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	1.01e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	1e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	1e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CCL5—atopic dermatitis	9.98e-06	0.000122	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	9.9e-06	0.000121	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MAPK8—atopic dermatitis	9.89e-06	0.000121	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	9.89e-06	0.000121	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	9.86e-06	0.000121	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	9.83e-06	0.000121	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	9.8e-06	0.00012	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	9.71e-06	0.000119	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—IL2—atopic dermatitis	9.68e-06	0.000119	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NGF—atopic dermatitis	9.59e-06	0.000118	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PPARA—atopic dermatitis	9.57e-06	0.000117	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	9.55e-06	0.000117	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NGF—atopic dermatitis	9.44e-06	0.000116	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NGF—atopic dermatitis	9.42e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	9.41e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	9.39e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NGF—atopic dermatitis	9.38e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	9.37e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NGF—atopic dermatitis	9.36e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	9.34e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	9.33e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CCR5—atopic dermatitis	9.33e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	9.31e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	9.27e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NGF—atopic dermatitis	9.26e-06	0.000114	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NGF—atopic dermatitis	9.24e-06	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	9.22e-06	0.000113	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—CXCL8—atopic dermatitis	9.2e-06	0.000113	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	9.18e-06	0.000113	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CCR5—atopic dermatitis	9.16e-06	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	9.13e-06	0.000112	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL2—atopic dermatitis	9.12e-06	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	9.1e-06	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	9.01e-06	0.000111	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	8.99e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CCR5—atopic dermatitis	8.99e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	8.98e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	8.96e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL2—atopic dermatitis	8.96e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	8.93e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	8.9e-06	0.000109	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	8.81e-06	0.000108	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PPARA—atopic dermatitis	8.79e-06	0.000108	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL2—atopic dermatitis	8.79e-06	0.000108	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	8.72e-06	0.000107	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	8.58e-06	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	8.58e-06	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	8.55e-06	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	8.35e-06	0.000102	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	8.3e-06	0.000102	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	8.19e-06	0.0001	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	8.17e-06	0.0001	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL2—atopic dermatitis	7.93e-06	9.73e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	7.91e-06	9.7e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—IL6—atopic dermatitis	7.89e-06	9.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	7.84e-06	9.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL2—atopic dermatitis	7.82e-06	9.6e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	7.78e-06	9.55e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	7.78e-06	9.54e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	7.76e-06	9.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	7.74e-06	9.49e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	7.72e-06	9.46e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	7.64e-06	9.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NFKBIA—atopic dermatitis	7.62e-06	9.35e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL2—atopic dermatitis	7.49e-06	9.19e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	7.47e-06	9.16e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	7.45e-06	9.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	7.37e-06	9.04e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	7.37e-06	9.04e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	7.3e-06	8.95e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	7.2e-06	8.83e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL2—atopic dermatitis	7.14e-06	8.76e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—IL6—atopic dermatitis	7.1e-06	8.71e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	7.08e-06	8.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	7.04e-06	8.64e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL2—atopic dermatitis	7.04e-06	8.64e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	7.01e-06	8.6e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—IL6—atopic dermatitis	7.01e-06	8.6e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	6.9e-06	8.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	6.65e-06	8.16e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	6.57e-06	8.06e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	6.48e-06	7.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	6.48e-06	7.95e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	6.39e-06	7.84e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	6.36e-06	7.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	6.33e-06	7.76e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—IL6—atopic dermatitis	6.32e-06	7.75e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PPARA—atopic dermatitis	6.24e-06	7.65e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	6.22e-06	7.62e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	6.12e-06	7.5e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL2—atopic dermatitis	6.11e-06	7.49e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	6.08e-06	7.45e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	5.94e-06	7.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	5.91e-06	7.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	5.85e-06	7.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	5.85e-06	7.17e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	5.82e-06	7.13e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	5.64e-06	6.92e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	5.62e-06	6.89e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	5.55e-06	6.81e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	5.54e-06	6.79e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	5.52e-06	6.77e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	5.5e-06	6.75e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	5.47e-06	6.71e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	5.45e-06	6.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CXCL8—atopic dermatitis	5.43e-06	6.66e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL2—atopic dermatitis	5.39e-06	6.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	5.38e-06	6.6e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL6—atopic dermatitis	5.36e-06	6.58e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL2—atopic dermatitis	5.3e-06	6.5e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL2—atopic dermatitis	5.29e-06	6.49e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARA—atopic dermatitis	5.29e-06	6.48e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	5.28e-06	6.47e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL2—atopic dermatitis	5.27e-06	6.47e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL6—atopic dermatitis	5.27e-06	6.46e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL2—atopic dermatitis	5.26e-06	6.45e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	5.25e-06	6.44e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	5.23e-06	6.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL2—atopic dermatitis	5.21e-06	6.39e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL2—atopic dermatitis	5.19e-06	6.37e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	5.18e-06	6.35e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL6—atopic dermatitis	5.17e-06	6.34e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	5.05e-06	6.19e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	4.96e-06	6.08e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	4.88e-06	5.99e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	4.87e-06	5.97e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	4.86e-06	5.96e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	4.84e-06	5.94e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	4.82e-06	5.92e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	4.8e-06	5.89e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	4.79e-06	5.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MAPK8—atopic dermatitis	4.78e-06	5.86e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—atopic dermatitis	4.66e-06	5.72e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—atopic dermatitis	4.6e-06	5.64e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	4.44e-06	5.45e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—atopic dermatitis	4.4e-06	5.4e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—atopic dermatitis	4.2e-06	5.15e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	4.14e-06	5.08e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—atopic dermatitis	4.14e-06	5.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	3.74e-06	4.58e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—atopic dermatitis	3.59e-06	4.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	3.49e-06	4.28e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	3.44e-06	4.21e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—atopic dermatitis	3.17e-06	3.89e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—atopic dermatitis	3.12e-06	3.82e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—atopic dermatitis	3.11e-06	3.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—atopic dermatitis	3.1e-06	3.8e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—atopic dermatitis	3.09e-06	3.79e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—atopic dermatitis	3.06e-06	3.75e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—atopic dermatitis	3.05e-06	3.74e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	2.84e-06	3.48e-05	CbGpPWpGaD
